[go: up one dir, main page]

YU57601A - Epotilon derivati, postupak za njihovu izradu i njihova farmaceutska primena - Google Patents

Epotilon derivati, postupak za njihovu izradu i njihova farmaceutska primena

Info

Publication number
YU57601A
YU57601A YU57601A YUP57601A YU57601A YU 57601 A YU57601 A YU 57601A YU 57601 A YU57601 A YU 57601A YU P57601 A YUP57601 A YU P57601A YU 57601 A YU57601 A YU 57601A
Authority
YU
Yugoslavia
Prior art keywords
methyl
residue
pyridyl
hydrogen
group
Prior art date
Application number
YU57601A
Other languages
English (en)
Inventor
Ulrich Klar
Werner Skuballa
Bernd Buchmann
Wolfgang Schwede
Michael Schirner
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999107480 external-priority patent/DE19907480A1/de
Priority claimed from DE19954229A external-priority patent/DE19954229A1/de
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of YU57601A publication Critical patent/YU57601A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Ovaj pronalazak opisuje nove epotilon derivate opste formule (I) u kojoj znace R4 vodonik, C1-C10-alkil, aril, C7-C20-aralkil, R5 vodonik, C1-C10-alkil, aril, C7-C10-aralkil, R6 i R7 po vodonik, zajedno dodatnu vezu ili atom kiseonika, R8 metil grupu ili vodonik, kao i da stoje X za 2-piridil, 2-metil-4-tiazolil ili 2-metil-oksazolil ostatak ili jednovremeno R1a i R1b zajedno za trimetilen grupu, R2 za metil, etil ili propil grupu kao i X za 2-piridil, 2-metil-4-tiazolil ili 2-metil-4-oksazolil ostatak ili jednovremeno R1a i R1b uvek za metil grupu, R2 za metil, etil, ili propil i X za 2-piridil, 2-metil-tiazolil ili 2-metil-4-oksazolil ostatak, pri cemu atom azota i/ili sumpora u X moze da se nalazi u oksidovanom obliku i pri cemu, kada R2 i R8 uvek znace metil ostatak, X moze da bude samo u datom slucaju na atomu azota oksidovani 2-piridil ostatak, ukljucujuci sve moguce stereoizomere kao i njihove smese. Nova jedinjenja su podesna za izradu lekova.
YU57601A 1999-02-11 2000-02-11 Epotilon derivati, postupak za njihovu izradu i njihova farmaceutska primena YU57601A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1999107480 DE19907480A1 (de) 1999-02-11 1999-02-11 Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
DE19954229A DE19954229A1 (de) 1999-11-04 1999-11-04 Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung

Publications (1)

Publication Number Publication Date
YU57601A true YU57601A (sh) 2005-06-10

Family

ID=26051977

Family Applications (1)

Application Number Title Priority Date Filing Date
YU57601A YU57601A (sh) 1999-02-11 2000-02-11 Epotilon derivati, postupak za njihovu izradu i njihova farmaceutska primena

Country Status (21)

Country Link
US (2) US7001916B1 (sh)
EP (1) EP1161430A2 (sh)
JP (1) JP2002536450A (sh)
KR (1) KR20010094763A (sh)
CN (1) CN1340053A (sh)
AU (1) AU4101800A (sh)
BG (1) BG105803A (sh)
BR (1) BR0008206A (sh)
CA (1) CA2360952A1 (sh)
CZ (1) CZ20012886A3 (sh)
EA (1) EA200100833A1 (sh)
EE (1) EE200100422A (sh)
HK (1) HK1044946A1 (sh)
HU (1) HUP0105330A2 (sh)
IL (1) IL144370A0 (sh)
MX (1) MXPA01008148A (sh)
NO (1) NO20013900L (sh)
PL (1) PL350190A1 (sh)
SK (1) SK11452001A3 (sh)
WO (1) WO2000047584A2 (sh)
YU (1) YU57601A (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6242469B1 (en) 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6660758B1 (en) * 1996-12-13 2003-12-09 The Scripps Research Institute Epothilone analogs
AU772750C (en) * 1999-04-30 2005-02-24 Schering Aktiengesellschaft 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
DE60232719D1 (de) * 2001-02-27 2009-08-06 Novartis Ag Kombination enthaltend einen inhibitor der signaltransduktion und ein epothilonderivat
CN100536841C (zh) * 2001-08-23 2009-09-09 诺瓦提斯公司 环丙基和环丁基埃坡霉素类似物
DK1483251T3 (da) 2002-03-12 2010-04-12 Bristol Myers Squibb Co C3-cyano-epothilon-derivater
AU2003242646A1 (en) * 2002-06-10 2003-12-22 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
RU2379032C9 (ru) * 2002-06-10 2010-03-27 Новартис Аг Комбинации, включающие эпотилоны, и их фармацевтическое применение
JP4328293B2 (ja) * 2002-07-31 2009-09-09 メルシャン株式会社 新規生理活性物質
US20050215604A1 (en) * 2004-03-26 2005-09-29 Kosan Biosciences, Inc. Combination therapies with epothilones and carboplatin
EP1589011A1 (en) * 2004-04-22 2005-10-26 Schering Aktiengesellschaft Novel chiral heptyne derivates for the preparation of epothilones and processes for their preparation
JP2008536479A (ja) 2005-02-11 2008-09-11 ユニバーシティ オブ サザン カリフォルニア ジスルフィド架橋を有するタンパク質の発現法
EP2029156A4 (en) * 2006-05-01 2010-07-21 Univ Southern California COMBINATION THERAPY FOR CANCER TREATMENT
US20100113128A1 (en) * 2008-11-05 2010-05-06 Snow Richard N Methods and apparatus for determining a reel strip position
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
US20100125146A1 (en) * 2008-11-19 2010-05-20 Johnson Matthey Public Limited Company Method for making pharmaceutical compounds
WO2011146638A1 (en) 2010-05-18 2011-11-24 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
BR112018007673A2 (pt) 2015-10-16 2018-11-06 Univ Rice William M ?análogos de epotilona, métodos de síntese, métodos de tratamento e conjugados de fármaco dos mesmos?
WO2017096559A1 (en) 2015-12-09 2017-06-15 Rhodia Operations Production of xylene derivatives

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
US5469145A (en) 1992-05-29 1995-11-21 Johnson; Lonnie Wet diaper detector
US6288237B1 (en) 1995-11-17 2001-09-11 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Epothilons C and D, preparation and compositions
US6441025B2 (en) 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
DE19636343C1 (de) 1996-08-30 1997-10-23 Schering Ag Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B
NZ334821A (en) 1996-08-30 2000-12-22 Novartis Ag Method for producing epothilones
US5969145A (en) 1996-08-30 1999-10-19 Novartis Ag Process for the production of epothilones and intermediate products within the process
US6867305B2 (en) * 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6242469B1 (en) * 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6441186B1 (en) * 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
DE19701758A1 (de) 1997-01-20 1998-07-23 Wessjohann Ludgar A Dr Epothilone-Synthesebausteine
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
AU9340998A (en) * 1997-08-09 1999-03-01 Schering Aktiengesellschaft New epothilone derivatives, method for producing same and their pharmaceutical use
AU4775299A (en) 1998-06-22 2000-01-10 Nicolaou, Kyriacos Costa Desmethyl epothilones
AU6208701A (en) 2000-03-09 2001-09-17 Schering Aktiengesellschaft Radioactively labeled epothilone derivatives, method for the production thereof, and their biochemical and pharmaceutical use
CA2359267A1 (en) 2000-10-19 2002-04-19 Manabu Takami Wavelength selecting module and wavelength selecting apparatus
EP1340498A1 (en) * 2002-03-01 2003-09-03 Schering Aktiengesellschaft Use of epothilones in the treatment of brain diseases associated with proliferative processes
CA2492437A1 (en) * 2002-07-31 2004-02-12 Schering Ag New effector conjugates, process for their production and their pharmaceutical use
US7138279B2 (en) 2002-08-13 2006-11-21 Kosan Biosciences, Inc. Transposon-based transformation system

Also Published As

Publication number Publication date
US7001916B1 (en) 2006-02-21
SK11452001A3 (sk) 2002-04-04
PL350190A1 (en) 2002-11-18
BR0008206A (pt) 2002-02-19
IL144370A0 (en) 2002-05-23
NO20013900L (no) 2001-10-11
MXPA01008148A (es) 2003-07-21
BG105803A (en) 2002-03-29
KR20010094763A (ko) 2001-11-01
JP2002536450A (ja) 2002-10-29
AU4101800A (en) 2000-08-29
US20060040990A1 (en) 2006-02-23
CA2360952A1 (en) 2000-08-17
CN1340053A (zh) 2002-03-13
EE200100422A (et) 2002-12-16
HUP0105330A2 (hu) 2002-05-29
NO20013900D0 (no) 2001-08-10
CZ20012886A3 (cs) 2001-11-14
WO2000047584A2 (de) 2000-08-17
EA200100833A1 (ru) 2002-02-28
WO2000047584A3 (de) 2000-12-28
EP1161430A2 (de) 2001-12-12
HK1044946A1 (zh) 2002-11-08

Similar Documents

Publication Publication Date Title
YU57601A (sh) Epotilon derivati, postupak za njihovu izradu i njihova farmaceutska primena
HUP0302380A2 (hu) Cisztein-proteázok reverzibilis inhibitoraiként alkalmazható új spiroheterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
EA200800285A1 (ru) Новые производные 2,4-дианилинопиримидинов, их получение, лекарственные средства, фармацевтические композиции, содержащие указанные производные, и их применение, в частности, в качестве ингибиторов ikk
NZ536734A (en) Spiroindolinepiperidine derivatives
HUP0302274A2 (hu) 2,4,8-Triszubsztituált-8H-pirido[2,3-d]pirimidin-7-on-vegyületek és felhasználásuk CSBP/p38 kináz által mediált betegségek kezelésére, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0302167A2 (hu) Metabotropikus glutamát receptor antagonista hatású kinolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
PA8539501A1 (es) Compuestos triazolo como inhibidores de mmp
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
HUP0100579A2 (hu) Amino-vajsav-származékok és ezeket tartalmazó gyógyszerkészítmények
HUP9802937A2 (hu) Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
NO20076006L (no) Acetylenderivater
HUP0401886A2 (hu) Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
TW200745034A (en) New compounds
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EA200101224A1 (ru) Производные пурина, способ их получения и содержащие их фармацевтические композиции
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0000719A2 (hu) Aril-piperidino-propanol- és aril-piperazino-propanol-származékok, és ilyen vegyületeket tartalmazó gyógyászati készítmények
HUP9801072A2 (hu) Szubsztituált 6-és 7-amino-tetrahidro-izokinolin-karbonsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
TW200616636A (en) Novel compounds
HUP0401733A2 (hu) Ciklikus aminszármazékok és ezeket tartalmazó gyógyszerkészítmények
TW200619212A (en) Morpholine derivatives
IS2472B (is) Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau